Brands: Vuity · Pilocarpine Hydrochloride
Average across 9 priced NDCs. A benchmark of pharmacy acquisition cost - not a retail quote.
Prescriptions dispensed under Medicaid (fee-for-service + managed care), summed nationally. The closest free proxy to sales volume - Medicaid only, not all-payer.
US labelers as registered with FDA. Repackagers relabel another company's product; share* is of listed packages, not sales.
| Labeler | Type | Packages | Status |
|---|---|---|---|
| Amneal Pharmaceuticals LLC | generic | 5 | SUPPLYING |
| Sandoz Inc | generic | 3 | SUPPLYING |
| AbbVie Inc. | unknown | 2 | EXITED 2026 |
Shortages, recalls, and registration changes attached to this drug concept.
Pilocarpine Hydrochloride Ophthalmic Solution — reported in shortage by AbbVie Inc.. Therapeutic category: Ophthalmology.
Pilocarpine Hydrochloride Ophthalmic Solution — reported in shortage by AbbVie Inc.. Therapeutic category: Ophthalmology.
Failed Impurities/Degradation Specifications. — Recalling firm: Novartis Pharmaceuticals Corp. — nationwide
